Apple says new CareKit platform will ‘empower’ Parkinson’s patients
Author: Geoffrey ChangPublished: 24 March 2016
Prep: Cook: Serves:
People with Parkinson’s will be among the first to experience the benefits of Apple’s new open-source health-tracking platform, which will ‘empower’ patients – and could transform the way we think about health
Apple has revealed a new health-tracking software platform at its ‘Loop You In’ product launch event. CareKit is a software framework designed for apps that let people with Parkinson’s and other chronic diseases better understand and manage their condition.
With the introduction of the platform, Apple aims to put patients back in charge of tracking symptoms and medications with the use of a smartphone.
Though CareKit won’t be fully available until next month, one of the apps to have first access to the platform is for people with Parkinson’s, and will monitor the effectiveness of medication used to treat the condition.
Jeff Williams, Chief Operating Officer of Apple, said: “We believe that giving individuals the tools to understand what is happening with their health is incredibly powerful. Apps designed using CareKit make this a reality by empowering people to take a more active role in their care.”
After the success of ResearchKit, the study-focused platform that enabled medical researchers to gather highly individualised data on a large-scale, Apple decided to widen the scope from medical research to personal care with the development of CareKit.
Developed by Sage Bionetworks and the University of Rochester, the first app built for ResearchKit was mPower, which claims to be responsible for the biggest Parkinson’s study to date.
Dr Stephen Friend, president of Sage Bionetworks, said: “mPower allows researchers to follow day-to-day fluctuations in Parkinson’s disease symptoms and allows for insights that would be impossible to achieve when a patient is only being examined every six months.
“This kind of data has never been tracked and captured before, and now with the help of CareKit, we can provide quantitative insights to inform the dialogue a person has with a health professional about his or her own disease.”
CareKit will be available in April. For more information click here
How CareKit could benefit people with Parkinson’s
Apps built for CareKit will be able to utilise specialised ‘modules’ such as the so-called ‘Care Card’, ‘Insight Dashboard’, ‘Symptoms and Measurement tracker’ and ‘Connect’.
Here’s how the modules could work with Parkinson’s apps:
‘Care Card’ keeps tabs on your medication or physical therapy needs, essentially creating interactive to-do lists that remind you when to take your medicine.
‘Insight Dashboard’ maps progress over time and can reveal which treatments are actually working in relation to symptom fluctuation.
‘Symptoms and Measurement tracker’takes advantage of the iPhone’s high-tech sensory capabilities such as accelerometers, microphones, gyroscopes, cameras and GPS. For example, the phone’s microphone can record and analyse the subtle changes in the voice of Parkinson’s patients, or the gyroscope and accelerometers can sense a range of motions like fluctuations in gait.
‘Connect’ allows all this information to be shared with doctors, healthcare teams and family members.
How to stay connected when living with Parkinson’s disease
23 hours ago
Sir Billy Connolly: Parkinson’s disease is “like a strange animal”
Scottish comedian, actor and musician Sir Billy Connolly has recently discussed his experience of Parkinson’s disease while promoting his new autobiography, ‘Windswept & Interesting’. In an appearance on UK talk show, ‘The Graham Norton Show’, the comedian explained that he had lost the ability to write. He said: “It breaks my heart as I used to love writing letters to people.” Speaking to UK newspaper The Guardian, Connolly added that he thinks the condition is “like a strange animal. One that sits beside you and says, ‘How will you get on without this?’ – before it takes away something else.” Despite these adjustments, Connolly told Norton he has “good days and bad days” with the condition. “It’s creeping up on me and it never lets go,” he said. “I walk like a drunk man and have to have help. So, life is different, but it is good.” Lead image credit:…
New insights on immune cell process and Parkinson’s disease
Insoluble clumps of the protein alpha-synuclein, which can cause damage to brain cells, have been previously linked to Parkinson’s. Now, scientists in Germany, France and the US have uncovered new details on how brain cells respond to these clusters. The researchers discovered that the brain’s immune cells may be able to join together to break down the protein clumps. According to a press release, this was previously unknown. They also found that these neighbouring cells share mitochondria – structures that generate energy for chemical reactions – to help one another. In certain mutations associated with Parkinson’s, this process may be impaired. The researchers hope this insight could inform the development of new therapies. “We have opened the door to a field that will certainly engage researchers for many years to come,” said Professor Dr Michael Heneka, director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital…
Could analysing skin oil help diagnose Parkinson’s disease?
Parkinson’s disease patients tend to have high levels of oil, known as sebum, on their skin’s surface. Now, a study has suggested that analysing this substance may help when diagnosing the condition. The study revealed that sebum contains significant amounts of genetic material, specifically the molecule ribonucleic acid (RNA). Analysis of RNA contained in sebum – that is, skin surface lipids RNA, or SSL-RNA – could offer insights into a person’s health. Researchers in Japan examined SSL-RNA in men and women with and without Parkinson’s. The results suggested that the SSL-RNA profiles of those with Parkinson’s had “different characteristics” than those without. The researchers then tested whether examining these profiles with machine learning could reveal those who had Parkinson’s – and who didn’t. The team’s algorithm indicated a “relatively robust discriminatory ability,” supporting the further use of SSL-RNA as part of a future “non-invasive” method for diagnosis.